Apr 20, 2026

Featuring perspectives from Dr Amir Fathi and Dr Eunice S Wang, including the following topics:

• Introduction: Overview — Biopharmacologic Considerations (0:00)
• Menin Inhibitor Monotherapy (21:51)
• Differentiation Syndrome (36:12)
• Menin Inhibitor Combination Approaches (45:15)
• Future Directions (49:59)
• PARADIGM —...

Apr 20, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Menin Inhibitors in Acute Myeloid Leukemia | Faculty Presentation 1: Biology Underlying the Utility of Menin Inhibitors in Acute Leukemias: Use of These Agents as Monotherapy — Eunice S Wang, MD

CME information and...

Apr 20, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Menin Inhibitors in Acute Myeloid Leukemia | Faculty Presentation 2: Potential Role of Menin Inhibitors as a Component of Combination Therapy — Amir Fathi, MD

CME information and select...

Apr 11, 2026

Featuring perspectives from Dr Paul G Richardson, including the following topics:

• EXCALIBER-RRMM: A Phase III trial of iberdomide, daratumumab and dexamethasone for relapsed/refractory multiple myeloma (0:00)
  • Lonial S et al. EXCALIBER-RRMM: A phase III trial of iberdomide, daratumumab, and dexamethasone...

Apr 1, 2026

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

• Case: A man in his early 40s with chronic immune thrombocytopenia (ITP) receives romiplostim with rituximab — Bhavana (Tina) Bhatnagar, DO (0:00)
• Case: A woman in her early 80s with metastatic adenocarcinoma of the lung responds to...